4DMedical (ASX:4DX) ROCE % : -43.07% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is 4DMedical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. 4DMedical's annualized ROCE % for the quarter that ended in Dec. 2024 was -43.07%.

4DMedical ROCE % Historical Data

The historical data trend for 4DMedical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4DMedical ROCE % Chart

4DMedical Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

ROCE %

-22.19

-47.94

-43.07

-41.61

4DMedical Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROCE %	Get a 7-Day Free Trial					-55.62	-48.13	-33.51	-39.42	-43.07

4DMedical ROCE % Calculation

4DMedical's annualized ROCE % for the fiscal year that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	-35.922	/	( ( (92.924 - 17.072)	+	(121.713 - 24.884) )	/ 2 )
	=	-35.922	/	( (75.852	+	96.829)	/ 2 )
	=	-35.922	/	86.3405
	=	-41.61 %

4DMedical's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	-38.07	/	( ( (121.713 - 24.884)	+	(102.014 - 22.064) )	/ 2 )
	=	-38.07	/	( ( 96.829	+	79.95 )	/ 2 )
	=	-38.07	/	88.3895
	=	-43.07 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

4DMedical (ASX:4DX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

4DMedical ROCE % Related Terms

Thank you for viewing the detailed overview of 4DMedical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

4DMedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 4DMedical Ltd (ASX:4DX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053

Website

https://www.4dmedical.com

4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.

4DMedical Headlines

No Headlines